The Opioid-Sparing Effects of Intravenous Ketorolac as an Adjuvant Analgesic in Cancer Pain: Application in Bone Metastases and the Opioid Bowel Syndrome
- 30 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 16 (5), 334-339
- https://doi.org/10.1016/s0885-3924(98)00081-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- KetorolacDrugs, 1997
- Balanced analgesia with intravenous ketorolac and patient-controlled morphine following lower abdominal surgeryJournal of Clinical Anesthesia, 1995
- Absorption of Transdermally Delivered Ketorolac Acid in HumansJournal of Pharmaceutical Sciences, 1995
- Comparison of Morphine and Ketorolac for Intravenous Patient-Controlled Analgesia in Postoperative Cancer PatientsThe Clinical Journal of Pain, 1994
- Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related painPublished by Oxford University Press (OUP) ,1994
- Tolerability of ketorolac administered via continuous subcutaneous infusion for cancer pain: A preliminary reportJournal of Pain and Symptom Management, 1994
- Use of Ketorolac after Lower Abdominal Surgery Effect on Analgesic Requirement and Surgical OutcomeAnesthesiology, 1994
- Subcutaneous ketorolac- a new development in pain controlPalliative Medicine, 1993
- A pilot study, review of the literature, and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer painPalliative Medicine, 1992
- KetorolacDrugs, 1990